批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2026/04/06 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 无 |
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:5MG;500MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 205649 |
001 |
NDA |
XIGDUO XR |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
Yes |
No |
AB |
2014/10/29
|
ASTRAZENECA AB |
| 211466 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MICRO LABS |
| 211479 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MSN |
| 211489 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
AUROBINDO PHARMA |
| 211536 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
CIPLA LTD |
| 211559 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MACLEODS PHARMS LTD |
| 211563 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
ALKEM LABS LTD |
| 211579 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
LUPIN LTD |
| 211583 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
TEVA PHARMS USA INC |
>>>活性成分:DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:5MG;1GM; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 205649 |
002 |
NDA |
XIGDUO XR |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
Yes |
No |
AB |
2014/10/29
|
ASTRAZENECA AB |
| 211466 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MICRO LABS |
| 211479 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MSN |
| 211489 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
AUROBINDO PHARMA |
| 211491 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
SUN PHARM |
| 211559 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MACLEODS PHARMS LTD |
| 211563 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
ALKEM LABS LTD |
| 211579 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
LUPIN LTD |
| 211583 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
TEVA PHARMS USA INC |
| 211595 |
001 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
5MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
CIPLA |
>>>活性成分:DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:10MG;500MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 205649 |
003 |
NDA |
XIGDUO XR |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
Yes |
No |
AB |
2014/10/29
|
ASTRAZENECA AB |
| 211466 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MICRO LABS |
| 211479 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MSN |
| 211489 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
AUROBINDO PHARMA |
| 211491 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
SUN PHARM |
| 211536 |
002 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
CIPLA LTD |
| 211559 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
MACLEODS PHARMS LTD |
| 211563 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
ALKEM LABS LTD |
| 211579 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
LUPIN LTD |
| 211583 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;500MG |
Prescription |
No |
No |
AB |
2026/04/06
|
TEVA PHARMS USA INC |
>>>活性成分:DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:10MG;1GM; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 205649 |
004 |
NDA |
XIGDUO XR |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
Yes |
Yes |
AB |
2014/10/29
|
ASTRAZENECA AB |
| 211466 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MICRO LABS |
| 211479 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MSN |
| 211489 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
AUROBINDO PHARMA |
| 211491 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
SUN PHARM |
| 211536 |
003 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
CIPLA LTD |
| 211559 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
MACLEODS PHARMS LTD |
| 211563 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
ALKEM LABS LTD |
| 211579 |
004 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
LUPIN LTD |
| 211583 |
005 |
ANDA |
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
10MG;1GM |
Prescription |
No |
No |
AB |
2026/04/06
|
TEVA PHARMS USA INC |